Evidence map›Paper›PMID 37959758›Full record

ArticleMolecules (Basel, Switzerland)2023

Atractylone in the

Ling Li, Yihao He, Nan Wang, Yuting Li, Yaoyao Du, Ning He, Bing Wang, Tong Zhang

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Effect ofFrontiers in pharmacology · 2025
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Anti-Molecules (Basel, Switzerland) · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Research Progress with Atractylone as an Antitumor Agent.Molecules (Basel, Switzerland) · 2024
    Review
  14. Effects of Crude Extract ofAntioxidants (Basel, Switzerland) · 2024
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ling LiSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.ORCID 0000-0002-6865-265X
Yihao HeSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Nan WangSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Yuting LiDepartment of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China.
Yaoyao DuSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Ning HeCollege of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China.
Bing WangShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Tong ZhangSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Shanghai University of Traditional Chinese Medicine · CNAnhui University of Traditional Chinese Medicine · CNChinese Academy of Sciences · CN

Funding

he National Natural Science Foundation of China general projects 82274066the National Key Research and Development Program of China 2022YFC3501705the program of Shanghai Leading Talents 2019100the Science and Technology Development Fund of Shanghai University of Traditional Chinese Medicine 23KFL046
6 · The paper itself

Abstract

The aim of this study was to conduct a screening of potential therapeutic compounds found in the

Indexed as

AtractylodesColitisColitis, UlcerativeOils, VolatileAnimalsAnti-Inflammatory AgentsColonDextran SulfateDisease Models, AnimalMiceMice, Inbred C57BLTumor Necrosis Factor-alphaAnti-Inflammatory AgentsDextran SulfateOils, VolatileTumor Necrosis Factor-alphaanti-inflammationantioxidative stressAtractylodes macrocephala rhizoma essential oilatractyloneintestinal injury reductionsignaling pathway

Identifiers

PMID37959758
PMCPMC10648463
OpenAlexW4388019775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.